Article
Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro
25 Nov 2020
Abstract excerpt
Pandemic spread of emerging human pathogenic viruses, such as the current SARS-CoV-2, poses both an immediate and future challenge to human health and society. Currently, effective treatment of infection with SARS-CoV-2 is limited and broad spectrum antiviral therapies to meet other emerging pandemics are absent leaving the World population largely unprotected. Here, we have identified distinct members of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
